Pure Global
NCT06390371

Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

Spotlight AQ Randomized Controlled Trial of the Spotlight AQ Survey Platform to Evaluate Its' Efficacy and Applicability in a Clinic Setting.
Children's Mercy Hospital Kansas City·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes Mellitus
Drug/Device/Intervention
Spotlight AQ Survey platform
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Children's Mercy Hospital Kansas City
Location
Kansas City, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 06, 2024
End date
Dec 01, 2024
Enrollment
60 participants
Primary outcome

HbA1c

Summary

The goal of this clinical trial is to compare the Spotlight AQ survey platform to the
 standard of care (SOC) pre-clinic assessment in adolescents & young adults (16-25 years old)
 with Type 1 Diabetes (T1D).
 
 The main questions it aims to answer are:
 
 - Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it?
 
 - Do patients and healthcare providers like using the spotlight AQ survey?
 
 Participants will use the Spotlight AQ survey before coming in to two standard of care T1D
 clinic visits Participants will fill out surveys describing how they feel about using the
 Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they
 feel about the Spotlight AQ survey.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06390371
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06390371 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Mercy Hospital Kansas City and is currently Recruiting. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.